How can life sciences companies navigate economic uncertainty in 2023?

Watch on-demand
Our seasoned panel, including Nina Kjellson, General Partner at Canaan and Bruce Booth, General Partner at Atlas Venture, shares their thoughts and predictions about what’s on the horizon and how companies can come out ahead.
Fill out the form to watch on-demand

Additional details

This webinar convenes some of the leading experts in biotech and pharma. In a podcast-style format, our panelists discuss:
  • The shifting macroeconomic environment in relation to life sciences
  • How funding and financial challenges continue to impact early-stage biotech companies
  • The implications M&A will have in relation to venture capital and IPOs
  • The impact of new innovations such as A.I., cell therapy, and more
  • Return-to-office trends and post-Covid productivity
  • Additional key takeaways for life sciences leaders and investors


Luke Timmerman,Founder & Editor, Timmerman Report
Luke Timmerman
Founder & Editor, Timmerman Report
Nina Kjellson,General Partner, Canaan
Nina Kjellson
General Partner, Canaan
Bruce Booth,General Partner, Atlas Venture
Bruce Booth
General Partner, Atlas Venture
Greg Bisconti,Executive Managing Director, JLL
Greg Bisconti
Executive Managing Director, JLL

Get in touch

We are here to answer your questions,
and help you get what you want.


Jones Lang LaSalle (JLL), together with its subsidiaries and affiliates, is a leading global provider of real estate and investment management services. We take our responsibility to protect the personal information provided to us seriously.

Generally the personal information we collect from you are for the purposes of dealing with your enquiry.

We endeavor to keep your personal information secure with appropriate level of security and keep for as long as we need it for legitimate business or legal reasons. We will then delete it safely and securely. For more information about how JLL processes your personal data, please view our privacy statement.